Berger Saskia, Hilgarth Heike, Fischer Andreas, Remane Yvonne, Schmitt Jochen, Knoth Holger
Klinik-Apotheke, Universitätsklinikum Carl Gustav Carus der Technischen Universität Dresden.
Zentrum für Evidenzbasierte Gesundheitsversorgung (ZEGV), Universitätsklinikum Carl Gustav Carus der Technischen Universität Dresden.
Dtsch Med Wochenschr. 2023 Nov;148(23):e113-e119. doi: 10.1055/a-2161-2655. Epub 2023 Oct 25.
Drug therapy is a high-risk process and requires special attention, especially at sectoral borders. Pharmaceutical services such as medication review are appropriate measures to identify drug-related problems and thus improve the safety of drug therapy. Risk-scoring tools have been described in the literature as helpful for prioritizing medication reviews for patients at high risk for drug-related problems.
In a multi-centre point prevalence study, we identified patients at increased risk for medication-related problems at hospital admission using the medication risk tool. In addition, the current level of implementation of pharmacy services was surveyed.
A total of 11 (58%; 11/19) hospital pharmacies in Saxony participated in the point prevalence survey. The scoring tool identified 32% (279/875) of patients at increased risk for medication-related problems (Meris score >12 group) at admission. Thereby, the number of drugs in the Meris score >12 group was 10.6 (average; standard deviation 3.5; n=279), while in the Meris score ≤12 group it was only five drugs per patient (average 4.6; standard deviation 2.8; n=596). The age of patients in the Meris score >12 group averaged 75.9 ± 11 years, while the age of patients in the Meris score ≤12 group averaged 60.6 ± 17.9 years.
Prioritization with the help of a risk-scoring tool is essential as pharmacy services in Saxon hospitals still need to be regularly established and in order to identify patients with an increased risk for drug-related problems at an early stage.
药物治疗是一个高风险过程，需要特别关注，尤其是在科室交界处。诸如用药评估等药学服务是识别药物相关问题从而提高药物治疗安全性的适当措施。文献中已描述风险评分工具有助于对药物相关问题高风险患者的用药评估进行优先级排序。
在一项多中心现患率研究中，我们使用用药风险工具识别入院时药物相关问题风险增加的患者。此外，还调查了药学服务的当前实施水平。
萨克森州共有11家（58%；11/19）医院药房参与了现患率调查。该评分工具识别出32%（279/875）的患者入院时药物相关问题风险增加（梅里斯评分>12组）。因此，梅里斯评分>12组患者的药物数量为10.6种（平均；标准差3.5；n = 279），而梅里斯评分≤12组患者每人只有5种药物（平均4.6种；标准差2.8；n = 596）。梅里斯评分>12组患者的平均年龄为75.9±11岁，而梅里斯评分≤12组患者的平均年龄为60.6±17.9岁。
借助风险评分工具进行优先级排序至关重要，因为萨克森州医院的药学服务仍需定期建立，以便早期识别药物相关问题风险增加的患者。
